Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 19 Neoplasms 18 Cancer Pain 6 Breast Neoplasms 5 Breakthrough Pain 5 Prostatic Neoplasms 4 Lung Neoplasms 4 Colonic Neoplasms 4 Agnosia 4 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Head and Neck Neoplasms 3 Chronic Pain 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain, Postoperative 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Burns 2 Anemia, Sickle Cell 2 post laminectomy syndrome 1 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vipoma 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1

Interventions

Surveys and Questionnaires 4 Acupuncture Therapy 2 Sugars 1 Rehabilitation 1 Oxygen 1 Lisinopril 1 Fentanyl 1 Exercise 1 Dexamethasone 1 Calcium Dobesilate 1 Buspirone 1 Behavior Therapy 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Dyspnea × Fentanyl × Clear all

NCT01515566 2014-08-22

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed

26 enrolled 7 charts

Dyspnea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡